TFEB and urinary bladder cancer: This observation opens the question whether post-translational modifications, such as acetylation, SUMOylation, PARsylation, or glycosylation in addition to phosphorylation21, or alternatively, different isoforms of TFEB could be more prevalent in the nuclear fraction of bladder cancer cells.